The effect of Butorphanol for postoperative pain relief and the prevention of postpartum depression in women undergoing cesarean delivery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024930

Enrollment

Unknown

Registered

2019-08-03

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

experimental group :Butorphanol injection

control group:Normal saline

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) undergoing cesarean delivery in Shengjing hospital; 2) the age of the pregnant is >= 20 and 50kg and 150cm and = 37 weeks and =2500 g and <= 4000 g.

Exclusion criteria

Exclusion criteria: 1) the pregnant has experienced depression before; 2) the pregnant has experienced domestic violence before; 3) the pregnant with a serious obstetric complication or serious foundational diseases; 4) the new born has serious genetic or congenital diseases; 5) multiple pregnancy.

Design outcomes

Primary

Measure	Time frame
Edinburgh Postnatal Depression Scale;sleep duration;	—

Secondary

Measure	Time frame
numerical rating scale;nausea and vomiting;	—

Countries

China

Contacts

Public ContactJiaxin Yao

Shengjing Hospital of China Medical University

1293920621@qq.com+86 18809809875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026